HP and metabolic syndrome: For instance, Chen et al. [56] demonstrated, in a Taiwan population, that Hp(+) patients were characterized by a higher HOMA–IR than their Hp-negative counterparts, and for patients younger than 50 years of age, Hp served as a predictor for MetS.